Methamphetamine is the most common and dangerous amphetamine in circulation today. In the United States, the overdose death rate linked to methamphetamine and similar stimulants nearly tripled between 2018 and 2023, climbing from 3.9 to 10.4 per 100,000 people. That rate now exceeds cocaine-related overdose deaths, making methamphetamine the deadliest stimulant in the country.
Why Methamphetamine Stands Apart
Amphetamines are a family of stimulant drugs. Some are prescribed legally for ADHD, including brand names like Adderall and Dexedrine. Methamphetamine is chemically similar to these medications but far more potent. Its structure allows it to cross into the brain more rapidly and in greater quantities, producing a more intense and longer-lasting high. While prescription stimulants account for only about 1.6% of stimulant-involved overdose deaths, methamphetamine dominates the illicit supply and drives the vast majority of amphetamine-related fatalities.
The DEA classifies all amphetamines, including methamphetamine, as Schedule II controlled substances, meaning they have a high potential for abuse that can lead to severe psychological or physical dependence. Methamphetamine does have one narrow medical use (a rarely prescribed ADHD medication called Desoxyn), but nearly all methamphetamine in circulation is manufactured illegally.
What It Does to the Heart
High blood pressure is the most common cardiovascular effect of amphetamine use, and methamphetamine pushes this to dangerous extremes. In studies of people admitted after amphetamine use, 43% showed a dangerously elevated heart rate, and another 34% had both a rapid heart rate and a prolonged electrical cycle in the heart, a combination that raises the risk of sudden cardiac arrest.
The damage goes well beyond blood pressure spikes. Methamphetamine can trigger chest pain, heart attacks, dangerous rhythm disturbances, and a condition where the heart muscle weakens and enlarges (cardiomyopathy). One study found that 84% of crystal methamphetamine users had cardiomyopathy and problems with how their heart pumped blood. Blood markers of heart muscle damage are consistently elevated in amphetamine users who show up in emergency departments, confirming that the drug is directly injuring the heart, not just stressing it temporarily. These cardiac effects can strike young, otherwise healthy people.
Physical Damage From Chronic Use
The visible toll of long-term methamphetamine use is distinctive. “Meth mouth,” the severe tooth decay associated with the drug, results from a combination of factors: methamphetamine dries out the mouth by reducing saliva production, and users grind and clench their teeth both day and night. Add in poor hygiene and a common habit of drinking sugary sodas, and the result is rapid, widespread tooth destruction. The pattern of decay mirrors what doctors see in other conditions that dry out the mouth, starting on the smooth surfaces of back teeth and between front teeth. Many young users end up needing full dentures.
Skin damage is equally characteristic. Roughly 40% of people in treatment for methamphetamine abuse report experiencing “formication,” the sensation of bugs crawling on or under the skin. Among those who have experienced drug-induced psychosis, that number jumps to 70%. This false sensation drives compulsive skin-picking that leaves scars on the face and arms. The constant picking, combined with neglected hygiene, opens the door to serious skin infections, including antibiotic-resistant staph infections.
Psychosis and Mental Health Effects
Heavy methamphetamine use can trigger a psychotic state that closely resembles schizophrenia. The most common symptoms are paranoid delusions, particularly the belief that others are trying to cause harm, followed by auditory and visual hallucinations. This typically happens alongside extreme agitation, making it one of the more dangerous psychiatric emergencies.
The good news is that amphetamine psychosis usually resolves with abstinence. About 82% of patients recover from the paranoid psychotic state within a month of stopping the drug. Clinicians distinguish it from schizophrenia largely by how quickly symptoms clear once the drug is out of the person’s system. However, recovery can be incomplete, and the lingering effects increase the risk of relapse.
The Fentanyl Contamination Risk
One of the newer dangers of illicit methamphetamine has nothing to do with methamphetamine itself. CDC-funded drug checking services found that about 12.5% of powder methamphetamine samples contained fentanyl, the synthetic opioid responsible for the majority of overdose deaths in the U.S. Crystal methamphetamine was far less likely to be contaminated (less than 1% of samples), but powder forms carry real risk.
This contamination helps explain why 43% of all stimulant-involved overdose deaths between 2021 and 2024 also involved opioids. People using methamphetamine may not know fentanyl is present, and because stimulant users often have no opioid tolerance, even a small amount of fentanyl can be lethal. Making this worse, when the veterinary sedative xylazine was also present in a sample, people’s ability to correctly identify whether their drugs contained fentanyl dropped from 92% to just 42%.
What Withdrawal Looks Like
Methamphetamine withdrawal is not typically life-threatening the way alcohol or benzodiazepine withdrawal can be, but it is physically and psychologically punishing. Symptoms begin within 24 hours of the last dose and unfold in two phases.
The first is the “crash,” which lasts about a week. During this period, people experience intense fatigue, increased appetite, and depressed mood. Clinician-rated assessments show these acute symptoms largely resolve within those first seven days. The second phase is a drawn-out period of subtler symptoms, including disrupted sleep (either too much or too little), continued overeating, and low motivation. This phase generally lasts about three weeks total, though some people experience lingering effects beyond that window.
Who Is Most Affected
Methamphetamine does not affect all communities equally. Among American Indian and Alaska Native populations, the overdose death rate involving methamphetamine-type stimulants surged from 11.0 per 100,000 in 2018 to 32.9 in 2023, more than three times the national average. Among Black Americans, cocaine-involved deaths are more prevalent, rising from 9.1 to 24.3 per 100,000 over the same period. These disparities reflect differences in drug supply, access to treatment, and the social determinants that shape substance use patterns across the country.
Prescription amphetamine misuse, while far less deadly, remains a concern in its own right. Among college students prescribed stimulants for ADHD, about 36% reported taking higher or more frequent doses than prescribed, and roughly 19% reported intentionally combining their medication with alcohol or other drugs. These behaviors carry their own cardiovascular and psychological risks, though they account for a tiny fraction of amphetamine-related deaths compared to illicit methamphetamine.